Venkys (India) Ltd

- There is no explicit mention of any current or planned new fundraising through debt or equity in the provided transcript. - The company has ongoing capital expenditure plans, such as the INR 70 crore expansion for SPF capacity and new plant commissioning for the Animal Health segment. - Existing capital expenditure is funded internally, with no direct reference to raising funds via debt or equity. - The company appears focused on capacity expansion, product innovation, and improving utilization, financed through operational cash flows. - No queries or answers during the call highlight intentions for new fundraising activities.

- INR 70 crores capex planned for SPF (Specific Pathogen Free) egg expansion; expected to complete in about 1 year and take 2 years to reach full production. Current SPF capacity utilization is 60-65%; expansion will add capacity of around 40,000 birds annually. - New animal health plant commissioned recently, operating at 55-60% capacity; exploring new product lines, expected to improve margins and contribute to 20% revenue growth in AHP segment for FY '26. - Strategic initiatives include starting production of ready-to-cook spices in the next quarter, targeting both local and export markets with authentic Indian taste products. - Focus on stable commodity prices (especially soya) to control production costs; maize price outlook uncertain and affects broiler hatching egg production costs. - Capacity expansions complemented by regulatory clearances and expected sustainable, respectable growth in coming years.

- Poultry segment is expected to grow 5%-10% in volume for FY '26 with improved realizations. - Animal Health (AHP) segment targets around 15%-20% growth; INR 340 crores revenue expected in FY '25 with 15% growth guidance for FY '26. - Expansion in SPF eggs capacity by 40,000 bird placements ongoing; potential for increased output if demand materializes. - Processed food (ready-to-eat/cook) segment growth projected at 25%-30% next year. - Soybean segment expects about 25% growth after degrowth last year. - New products and export initiatives underway to drive consistent and futuristic growth. - Marketing spends focused on quick commerce and e-commerce channels to fuel processed product sales growth. - Margin improvements expected with new capacities and processing plants stabilizing in Animal Health and other divisions.

- Poultry segment revenue expected to grow by around 5% to 10% in FY '26 with better realization anticipated (Vijay Tijare, Page 7). - Animal Health segment projected to grow at approximately 20% in FY '26, building on consistent past growth (Deepak Khosla, Pages 7, 18). - Oilseed segment profitability expected to improve with stable soya prices; however, not likely to reach past peak EBIT levels (J.K. Handa, Page 13). - SPF egg production expansion (INR 70 crores capex) underway, with capacity utilization currently at 60-65%, expected to enhance future earnings but takes about 2 years to fully contribute (J.K. Handa, Pages 11-12). - Ready-to-eat and ready-to-cook segments (retail and QSR) currently ~10% of poultry revenue and expected to grow by 25-30%, with Animal Health also contributing ~10%, providing pricing power and margin stability (Page 17). - Overall optimistic outlook with stable commodity prices and capacity expansions supporting moderate growth in operating earnings and profits.

- The transcript does not provide explicit details on the current or expected order book or pending orders for Venky's (India) Limited. - However, there is an indication that the company is optimistic about growth in various segments like Animal Health (AHP), ready-to-cook/ready-to-eat processed foods, and exports. - New product innovations and expansion (e.g., SPF egg capacity, processed food division) suggest an expected positive order inflow. - The company launched new product lines and markets through QSR, retail, and e-commerce, expecting 25-30% sales growth next year. - For the SPF egg production, capacity is at 188 lakh eggs with 40,000 bird placements under expansion, implying potential order increases as demand rises. - Overall, production and sales growth guidance for FY 2025-26 is optimistic, with segments like AHP expecting ~15% growth. *No specific numeric order backlog values are mentioned in the document.*